AAL

Clearside Biomedical Stock Crushes Shorts After Drug Data

It would take shorts more than a week to cover, at the average pace of trading

Mar 5, 2018 at 9:56 AM
facebook X logo linkedin


Shares of Clearside Biomedical Inc (NASDAQ:CLSD) are trading up 64.3% at $12.85 -- fresh off a 15-month high of $13.25, and on track for their biggest one-day gain ever. The drugmaker released positive topline data for its treatment on patients with macular edema associated with non-infectious uveitis, which is a build-up of fluid in the eye that negatively impacts vision.

Heading into today's trading, the shares had been chopping lower since topping $10 in late July, and hit a record low of $5.30 on Feb. 9. Short sellers, meanwhile, targeted CLSD stock during its recent technical troubles, with short interest surging 18.6% between the Feb. 1 and Feb. 15 reporting periods.

As such, it's likely a short squeeze is creating even bigger tailwinds for Clearside Biomedical shares. In fact, at the stock's average daily pace of trading, it would take more than a week to buy back these bearish bets.

Analysts, on the other hand, were already bullish on Clearside Biomedical, with all six covering analysts maintaining a "buy" or better rating. Plus, the average 12-month price target of $19.20 represented expected upside of nearly 146% to last Friday's close at $7.82.
 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.